Log in or Sign up for Free to view tailored content for your specialty!
Steatohepatitis/Metabolic Liver Disease News
Pre-pandemic ED visits for alcohol-related hepatitis rose by 4.4% among younger patients
An analysis of ED utilization from 2016 to 2019 revealed an increase in visits for alcohol-associated hepatitis, particularly among patients aged 25 to 44 years, as well as an increase in disease severity.
VIDEO: GIs will need to become ‘better at hepatology’ ahead of looming workforce shortage
In a Healio video exclusive, Edward V. Loftus Jr., MD, urged gastroenterologists to familiarize themselves with a “four-pronged approach to liver disease” ahead of the critical shortage of U.S. hepatologists expected by 2033.
Log in or Sign up for Free to view tailored content for your specialty!
Gastroenterologists should ‘start to own,’ embrace role in care for chronic liver disease
Chronic liver disease is the ninth leading cause of death in the United States, independent of liver cancer. According to the CDC, only 1.8% of adult Americans have a diagnosis of chronic liver disease, which translates to 4.5 million people.
MASLD requires multidisciplinary care to ‘improve global metabolic, liver health’
Finding adequate providers with the expertise to treat the growing population of patients with chronic liver diseases, including metabolic dysfunction-associated steatotic liver disease, is a challenging but important endeavor.
Early intervention critical, before ‘significant clinical toll’ from excessive alcohol use
Alcohol use disorder has a huge impact on liver health. Regardless of whether patients have other primary etiology for liver disease, alcohol — even in minimal amounts — can worsen liver outcomes.
GLP1s may lower 10-year risk for major adverse outcomes in chronic liver disease, diabetes
Adherence to treatment with glucagon-like peptide-1 receptor agonists may lower the long-term risk for major adverse liver outcomes among patients with chronic liver disease and type 2 diabetes, according to data in Gut.
FDA grants 510(k) clearance to Nanox AI software to assess ‘early signs’ of fatty liver
The FDA has granted 510(k) clearance to Nanox’s HealthFLD artificial intelligence software to aid clinicians in the detection of fatty liver associated with hepatic steatosis, according to a company press release.
Liver disease, frequency of alcohol-related care linked to mortality, hospital readmission
Individuals with alcohol-related liver disease and frequent health care utilization were at greater risk for mortality and hospital readmission, respectively, according to a cohort study of alcohol-related hospitalizations in Canada.
Women with concurrent MASLD, alcohol-related liver disease have 83% higher risk for death
Women with concurrent metabolic dysfunction-associated steatotic liver disease and alcohol-related liver disease had an 83% greater risk for all-cause mortality than men and those with ALD alone had 160% greater risk, data showed.
Chronic HBV ‘positively associates’ with severe necroinflammation in pediatric MASLD
Chronic hepatitis B virus infection was positively linked with severe hepatic necroinflammation in children with metabolic dysfunction-associated steatotic liver disease but did not appear to affect hepatic fibrosis, according to data.
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read
-
Headline News
Burnout, withdrawal remain ‘alarmingly high’ among physicians and residents
September 17, 20242 min read -
Headline News
Over one-third of adults not planning on receiving recommended vaccines this fall
September 18, 20242 min read -
Headline News
Popular home BP devices unable to provide accurate readings for millions due to sizing
September 19, 20242 min read